MA45770A - Peptides cycliques en tant qu'antagonistes du récepteur c5 - Google Patents

Peptides cycliques en tant qu'antagonistes du récepteur c5

Info

Publication number
MA45770A
MA45770A MA045770A MA45770A MA45770A MA 45770 A MA45770 A MA 45770A MA 045770 A MA045770 A MA 045770A MA 45770 A MA45770 A MA 45770A MA 45770 A MA45770 A MA 45770A
Authority
MA
Morocco
Prior art keywords
receptor antagonists
cyclic peptides
peptides
cyclic
antagonists
Prior art date
Application number
MA045770A
Other languages
English (en)
Inventor
Ye Che
Yiqing Feng
Matthew Merrill Hayward
David Hepworth
Peter Jones
Neelu Kaila
Nikolaos Papaioannou
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA45770A publication Critical patent/MA45770A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA045770A 2016-07-29 2017-07-17 Peptides cycliques en tant qu'antagonistes du récepteur c5 MA45770A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662368262P 2016-07-29 2016-07-29
US201762517215P 2017-06-09 2017-06-09

Publications (1)

Publication Number Publication Date
MA45770A true MA45770A (fr) 2019-06-05

Family

ID=59416754

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045770A MA45770A (fr) 2016-07-29 2017-07-17 Peptides cycliques en tant qu'antagonistes du récepteur c5

Country Status (13)

Country Link
US (1) US20190270778A1 (fr)
EP (1) EP3491005A1 (fr)
JP (1) JP2019532021A (fr)
KR (1) KR20190032534A (fr)
CN (1) CN109563136A (fr)
AU (1) AU2017304103A1 (fr)
BR (1) BR112019001217A2 (fr)
CA (1) CA3031895A1 (fr)
IL (1) IL264537A (fr)
MA (1) MA45770A (fr)
MX (1) MX2019001153A (fr)
SG (1) SG11201811412XA (fr)
WO (1) WO2018020358A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018119142A1 (fr) 2016-12-21 2018-06-28 Amgen Inc. Formulations d'anticorps anti-tnf alpha
KR20260023583A (ko) 2023-08-31 2026-02-20 후지필름 가부시키가이샤 표적화 약물 복합체 및 이것을 포함하는 의약, 및, 화합물
CN118490807A (zh) * 2024-05-09 2024-08-16 无锡市第二人民医院 一种补体C5a在制备治疗眼科疾病药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
AUPO755097A0 (en) 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
AUPR833401A0 (en) * 2001-10-17 2001-11-08 University Of Queensland, The G protein-coupled receptor antagonists
EP1498422A1 (fr) * 2003-07-17 2005-01-19 Jerini AG Antagonistes du Recepteur C5a
SG151283A1 (en) * 2004-03-26 2009-04-30 Promics Pty Ltd Treatment of neurological conditions using complement c5a receptor modulators
RU2007131267A (ru) * 2005-01-17 2009-02-27 Йерини Аг (De) АНТАГОНИСТЫ РЕЦЕПТОРА С5a

Also Published As

Publication number Publication date
AU2017304103A1 (en) 2019-01-17
MX2019001153A (es) 2019-06-10
WO2018020358A1 (fr) 2018-02-01
EP3491005A1 (fr) 2019-06-05
BR112019001217A2 (pt) 2019-04-30
IL264537A (en) 2019-02-28
JP2019532021A (ja) 2019-11-07
KR20190032534A (ko) 2019-03-27
CN109563136A (zh) 2019-04-02
CA3031895A1 (fr) 2018-02-01
SG11201811412XA (en) 2019-02-27
US20190270778A1 (en) 2019-09-05

Similar Documents

Publication Publication Date Title
EP3697759A4 (fr) Antagonistes du récepteur muscarinique de l'acétylcholine m4
MA50087A (fr) Vésicules extracellulaires provenant de prevotella
LT3762380T (lt) Fenilpirolidinono formilpeptido 2 receptoriaus antagonistai
PL3449940T3 (pl) Preparat zawierający przeciwciała
LT3143037T (lt) Alfa4beta7 integrino tioeterio peptidų antagonistaii
MA51232A (fr) Indane-amines utiles en tant qu'antagonistes de pd-l1
PL3283110T3 (pl) Przeciwciała skierowane przeciwko receptorowi interleukiny 36 (il-36r)
EP3344295A4 (fr) Récepteurs d'antigène chimère tn anti-sialyle
MA54653A (fr) Modulateurs du récepteur de cxcr7 pipéridine
HUE058759T2 (hu) Módszerek depresszió kezelésére orexin-2 receptor antagonisták alkalmazásával
EP3651762A4 (fr) Antagonistes du récepteur muscarinique de l'acétylcholine m4
EP3732163A4 (fr) Antagonistes du récepteur muscarinique de l'acétylcholine m4
EP3481814A4 (fr) Antagonistes de l'intégrine tetrahydronaphthyridinepentanamide
LT3713928T (lt) Nauji bradikinino b2 receptoriaus antagonistai
EP3349739A4 (fr) Diarylthiazepineamines carboxyliques utiles en tant qu'agonistes du récepteur opioïde mu
EP3697781A4 (fr) Antagonistes du récepteur muscarinique de l'acétylcholine m4
EP3665175A4 (fr) Antagonistes du récepteur muscarinique de l'acétylcholine m4
DK3448879T3 (da) Claudin-6 peptider
EP3684359C0 (fr) Antagonistes de trpv2
EP3350167A4 (fr) Antagonistes du récepteur des androgènes
DK3334721T3 (da) Cgrp-receptorantagonister
EP3551657A4 (fr) Récepteurs de chlorotoxines chimériques
EP3383388A4 (fr) Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
DK3380115T3 (da) Peptider fra piwil 1
MA45770A (fr) Peptides cycliques en tant qu'antagonistes du récepteur c5